PMI’s Smoke-Free Business Accounts for 43% of Net Revenues in Q1 as Full-Year EPS Guidance Rises

Apr.23
PMI’s Smoke-Free Business Accounts for 43% of Net Revenues in Q1 as Full-Year EPS Guidance Rises
On April 22, 2026, Philip Morris International released its first-quarter 2026 results. The report showed net revenues of $10.146 billion, up 9.1% year on year; adjusted diluted EPS of $1.96, up 16.0%; and smoke-free products accounting for 43% of total net revenues. Based on first-quarter performance, the company raised its 2026 full-year adjusted diluted EPS forecast to $8.36 to $8.51, or $8.11 to $8.26 excluding currency.

Key Takeaways

  • PMI reported Q1 2026 net revenues of $10.146 billion, up 9.1% year on year, or 2.7% organically.
  • Adjusted diluted EPS rose 16.0% to $1.96; excluding currency, it was $1.78, up 5.3%.
  • Smoke-free products accounted for 43% of total net revenues, and PMI smoke-free products are now available in 108 markets.
  • IQOS surpassed Marlboro to become the No. 1 nicotine “brand” in markets where present, reaching 10.9% share of combined cigarette and HTU industry volumes.
  • PMI raised its 2026 full-year adjusted diluted EPS forecast to $8.36 to $8.51.

2Firsts, April 22, 2026

 

Philip Morris International released its first-quarter 2026 earnings report, showing net revenues of $10.146 billion, up 9.1% year on year; adjusted diluted EPS of $1.96, up 16.0%; smoke-free products accounting for 43% of total net revenues; and an increased full-year adjusted diluted EPS forecast of $8.36 to $8.51.

 

Net revenues rose 9.1% to $10.146 billion


PMI said first-quarter 2026 net revenues were $10.146 billion, compared with $9.301 billion a year earlier, representing reported growth of 9.1% and organic growth of 2.7%. Within that total, international smoke-free net revenues increased 24.7% to $3.836 billion, international combustibles net revenues increased 6.8% to $5.688 billion, and U.S. net revenues declined 30.8% to $622 million.

 

Adjusted EPS increased 16.0% to $1.96


The company reported diluted EPS of $1.56, down 9.3% from $1.72 in the prior year, mainly due to a non-cash fair value adjustment related to its minority shareholding in India. Adjusted diluted EPS was $1.96, up from $1.69, representing 16.0% growth. Excluding currency, adjusted diluted EPS was $1.78, up 5.3%.

 

Operating income rose 9.8%, while adjusted operating margin reached 41.1%


PMI reported operating income of $3.893 billion, up 9.8% year on year. Adjusted operating income was $4.168 billion, compared with $3.790 billion a year earlier, representing growth of 10.0%. Adjusted operating income margin rose from 40.7% to 41.1%.

 

 

Smoke-free products contributed 43% of net revenues and remained the growth engine


PMI said smoke-free products accounted for 43% of total net revenues, up 1.3 percentage points from a year earlier. International smoke-free shipment volume grew 11.9%, while net revenues increased 24.7% on a reported basis and 15.8% organically. Gross profit in the segment rose 28.6% on a reported basis and 19.4% organically. PMI said smoke-free products remained the primary growth driver for the group.

 

IQOS continued to expand and surpassed Marlboro in markets where present


PMI said IQOS continued to lead global heat-not-burn category growth, with PMI holding about 77% volume share in the category. In Q1 2026, IQOS surpassed Marlboro to become the No. 1 nicotine “brand” in markets where present, with share of combined cigarette and HTU industry volumes rising 1.7 percentage points to 10.9%. HTU adjusted in-market sales increased 10.9%, while shipment volume rose 11.3% to 41.3 billion units.

 

In Japan, PMI said IQOS adjusted in-market sales rose by an estimated 10.4%, with total nicotine share reaching 34.9%. In Europe, IQOS adjusted in-market sales rose by an estimated 5.4%, with market share increasing to 12.6%. Outside Europe and Japan, adjusted in-market sales increased 19.4%.

 

Oral and e-vapor products continued to expand


PMI said modern oral shipment volume increased to 0.5 billion pouches, although declines in Nordic snus more than offset part of the gain, resulting in a 5.1% decline for total oral smoke-free shipment volume. ZYN is now available in 58 markets. In e-vapor, VEEV quarterly shipments exceeded one billion equivalent units for the first time and now shares the No. 1 position in Europe’s closed-pod category.

 

Combustibles still contributed, with Marlboro share reaching a record


PMI said international combustible shipment volume declined 5.1%, but net revenues still increased 6.8%, or 1.0% organically, mainly driven by strong pricing of 8.5%. Overall cigarette category share stood at 24.8%, while Marlboro gained 0.4 percentage points to a record first-quarter share of 10.7%.

 

U.S. business was pressured by ZYN inventory movements


PMI said U.S. ZYN offtake volumes, as estimated by Nielsen, grew 10%, but the overall U.S. business was affected by distributor and trade inventory movements in both the current and prior-year periods, as well as promotional comparisons. Total U.S. smoke-free shipment volume declined 21.2%, including a 23.5% drop in ZYN shipments to 2.3 billion pouches, or 155 million cans.

 

Full-year adjusted EPS guidance was raised to $8.36 to $8.51


Based on Q1 performance, PMI forecast full-year 2026 reported diluted EPS of $7.56 to $7.71. Excluding total adjustments of $0.80 per share, adjusted diluted EPS is projected at $8.36 to $8.51, up 10.9% to 12.9% from $7.54 in 2025. Excluding a favorable currency impact of $0.25, adjusted diluted EPS is projected at $8.11 to $8.26, representing growth of 7.5% to 9.5%.

 

The company also expects full-year 2026 organic net revenue growth of 5% to 7%, organic operating income growth of 7% to 9%, and second-quarter adjusted diluted EPS of $2.02 to $2.07.

 

Image Source: PMI 

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24
Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Pennsylvania began enforcing its electronic nicotine delivery system directory restrictions on October 19, 2026. Among 163 product listings recorded before enforcement, four CrossBar 20K disposables stood out with 13mL capacity, advertised puff counts of up to 20,000 and a flattened design distinct from conventional pod systems and compact disposables. Historical records identify earlier 1.3mL CrossBar products associated with Romo LLC, while newer 13mL products appeared in several state directories beginning in 2025 under entities including Blue Nine LLC. PMTA compliance expert Mr. K identified amendments and application ownership transfers as possible regulatory mechanisms, although neither has been confirmed in this case. Separately, Reynolds' $7.5 million acquisition of 16 PACHA products and related assets illustrates the commercial value of products linked to historic PMTA submissions.
Special Report
Oct.22
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
Former BAT global content lead Andy Parton has left the company and launched Destreza, a London-based AI-native marketing consultancy. Parton previously worked across BAT's New Category brands Vuse, Velo and glo and had also served as Global Brand Lead for Vuse Go. Destreza says it will advise consumer businesses on AI in brand strategy, operating models, capability and agency configuration, using specialist AI agents to support research, strategy and creative development. BAT reported £3.621 billion in New Category revenue in 2025.
Sep.22
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
China exported $979 million of vape-related products in August 2026, up 3.3% from a year earlier but down 6.4% from July. The UK replaced the U.S. as the main source of growth: UK-bound shipments jumped 51.4% to a 2026 high of $177 million, while exports to the U.S. fell 12.4% to $339 million. Shipments to markets outside the U.S. increased 14.2%, broadening growth beyond the market that had driven July’s rebound.
News
Sep.23 by 2Firsts Perspectives
Product | Japan Tobacco Expands Nordic Spirit Nicotine Pouch Range to Eight SKUs in Japan, Launches Melon Variant and Broadens Mint Retail Distribution
Product | Japan Tobacco Expands Nordic Spirit Nicotine Pouch Range to Eight SKUs in Japan, Launches Melon Variant and Broadens Mint Retail Distribution
Japan Tobacco Inc. (JT) launched Nordic Spirit Rich Melon Medium through selected tobacco retailers in Japan on November 2, 2026, while expanding physical retail distribution for three existing mint products previously sold through the CLUB JT online store. The melon launch brings Nordic Spirit's Japanese portfolio to eight SKUs. All four products are manufactured in Sweden, contain a standard 14 pouches per can and retail for ¥500 including tax. Since introducing Nordic Spirit in Japan in March, JT has expanded the brand's product lineup and distribution through its online store, convenience stores and selected tobacco retailers.
product
Nov.04
Philip Morris Malaysia Again Meets Religious Authority Over Cigarette Alternatives as Perlis Mufti Responds on Halal Criteria
Philip Morris Malaysia Again Meets Religious Authority Over Cigarette Alternatives as Perlis Mufti Responds on Halal Criteria
Philip Morris Malaysia Managing Director Naeem Shahab Khan met Perlis Mufti Mohd Asri Zainul Abidin on September 17 and presented the company's shift from conventional cigarettes toward alternative products. The mufti said a product could be considered halal if it is clean, its side effects are not harmful or can be controlled, and it does not involve excessive waste. His remarks did not mention IQOS or any other specific PMI product and did not amount to a new product-specific religious ruling. It was at least the second publicly reported engagement between Philip Morris Malaysia and a Malaysian religious institution over cigarette alternatives within six months.
Regulations
Sep.18 by 2Firsts Perspectives